The Gleason grading system: Aging like a fine wine
"As we celebrate 50 years of successes, the Gleason grading system deserves recognition," writes Michael S. Cookson, MD, MMHC.
LCD addresses NAAT panels for infectious disease testing
Labs will need to apply for unique Z code for each panel of tests ordered.
Man sues after delayed diagnosis of prostate cancer
Insurance company contributed to settlement without insured’s consent.
RP appears more effective against high-risk prostate cancer
"It’s very possible that the PSA screening-detected high-risk prostate cancer portends a more favorable outlook when compared with the pre-PSA era, regardless of the type of primary therapy utilized," writes Badar M. Mian, MD.
Debate continues on best strategy for small renal masses
Surgical approach and ischemia time are among key topics.
How to handle microaggressions and be aware of your own biases
Ekene Enemchukwu, MD, MPH, highlights her presentation, "Microaggressions 2.0 – How to survive and thrive," from the 2022 SUFU winter meeting.
Life insurance is a key piece of the financial puzzle
Which option you select depends on your goals and what you want to cover.
“A wild and woolly time”: Extracorporeal shock wave lithotripsy for kidney stones
In this installment of Urology Times' 50th Anniversary Innovation Celebration, James E. Lingeman, MD, discusses the development of extracorporeal shock wave lithotripsy for the treatment of kidney stones.
Ongoing advances in the perioperative management of bladder cancer
At the 2022 NY GU Cancers Symposium, Jean Hoffman-Censits, MD, discussed the latest developments in the neoadjuvant and adjuvant setting for patients with bladder cancer.
Dr. Nickel discusses saw palmetto as a complementary treatment for LUTS
"We shouldn't outright provide a negative attitude to our patients who are looking for alternatives that [serve as] complementary medicine, [like] herbal or phytotherapeutic agents," says J. Curtis Nickel, MD, FRCSC.
2 Clarke Drive Cranbury, NJ 08512